Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Cellular Communica-on Communication in the Work Place • Why is communication important in the workplace community? What are some reasons we need to communicate? • Why is it important to ensure proper communication? How could you communicate with someone…? In the office next to you? In the Provost’s office? At Berkley? One of our faculty visiting Japan? To get information to everyone in your department? How does a breakdown in communication impact the functioning of the business? • What happens if one department continues to hire without permission? • What happens if income is not brought in? Cell Communica,on is Important for Cells What are some reasons cells need to communicate? Why ensure proper communication? Yeast image courtesy of Dr. Maxim Zakhartsev and Doris Petroi, Frog image courtesy of Carole LaBonne Types of Communication Needed Between cells to generate Within the What does life do? It makes copies of itself. It creates order. subunits A T length DNA “Structure” Figure 17‐1 Molecular Biology of the Cell (© Garland Science 2008) System of Checks and Balances Designed to coordinate proper Cell cycle progression Weiss lab studies the spatial and temporal coordination of growth and division Errors in cell communica,on result in disease Cancer…uncontrolled cell prolifera,on and migra,on. Gene,c muta,ons of proteins that regulate signal pathways control cell division. Hyperac,va,on of proteins encouraging division or not enough from nega,ve regula,on (suppressor) Abelson tyrosine kinase signaling has been implicated in leukemia Diabetes (abnormally high blood sugar levels) occur as a result of errors in the levels of insulin produc,on, a failure of insulin receptor signaling or components of its relay pathway. How do cells communicate? Signal pathways allow communica,on across barriers Figure 10‐1 Molecular Biology of the Cell (© Garland Science 2008) Signal pathways allow amplifica,on of the signal Responses to signaling molecule vary based on receptor type and cell type Different receptors Same receptor, Different Cell Type SIGNAL INTEGRATION * NOT SHOWN HERE ARE INHIBITORY SIGNALS Cell-to-cell communication is necessary because… • Transfers the signal from the membrane to machinery elici-ng response • Amplifies the signal…a small ini-al s-mulus may be enhanced • Single signal may ac-vate mul-ple targets • Allows several levels for integra-on/regula-on of signals Cell Communica-on Cell signaling pathways provide cells with adaptability to changing environmental conditions and cellular demands. Cell-to-cell communication is necessary for disease prevention and regulating complex behaviors input Stimulus, signal, Target integration output response How is signaling between cells accomplished? In response to s,mulus, the ini-a-ng cell produces signaling molecule (i.e. an ac,vated protein, small pep,des, amino acids, nucleo,des, steroids, lipids, and gases) *1 Recipient cell needs receptor (whether on cell surface or internal protein) Variables influencing signaling: Distance *1 Specificity: Neighbors w/ receptors Time**: Variable Direct contact All distances Fast Slower (diffusion) **lasting on the order of milliseconds in the case of ion flux, but some can take even days (as is the case with gene expression), to complete. Variables influencing signaling: Localization of signal receptors *1 • Cell-surface receptors: Enzyme linked receptors, G-protein linked receptors, and ion-channel-linked receptor • Receptors are found intracellularly and upon ligand binding migrate to the nucleus where the ligand-receptor complex directly affects gene transcription. Variables influencing signaling: Signal Type *2 Methods of transmiang signal within the cell • conforma,onal changes • gene regula,on • protein modifica,on • genera,on of 2nd messenger • amplifica,on of signal • protein degrada,on • change in localiza,on • protein binding (adapters) • gradient differences Conforma,on changes • Ligand binding induces a change in the shape or conforma,on of the receptor • changes in conformation either result in the activation of an enzymatic activity contained within the receptor or expose a binding site for other proteins/DNA/RNA within the cell. Conformational change and gene regulation *DNA binding regulates gene expression *1 Protein modifica,ons Many chemical modifications change binding properties of the protein The two branches of the inositol phospholipid pathway Receptor point muta,on cause active conformation even in the absence of ligand-binding ("constitutively active"). *ligand induces conforma,onal change in receptor that causes dissocia,on of GDP and associa,on of GTP with trimeric G‐protein α subunit *1 Protein degrada,on In Notch-mediated signaling, activation of Notch can cause the Notch protein to be altered by a protease. Gradient signaling Some signaling transduction pathways respond differently depending on the amount of signaling received by the cell. For instance the hedgehog protein activates different genes depending on the amount of hedgehog protein present. Robert Holmgren’s lab studies Mayo group studies hormone regulation of the reproductive tissues such as ovaries and pituitary Act via 2nd messengers Receptors with kinase ac,vity Protein modifica,on, adaptor proteins, amplifica,on, mul,ple targets, 2nd messengers, …gene regula,on *2 Different regions of the protein may be important for separate pathways * *Other activated regions required to interact with adapter proteins. Adapter proteins facilitate interactions with other proteins, *2 Signal needs to be reversible…need to reset once s,mulus ends *2 Protein degrada,on, removal of modifica,ons, conversion of 2nd messengers *2 • Mul-ple inputs influencing transduc-on • Mul-ple levels that can be regulated Loops and feedback Negative feedback: the response negates the stimulus and shuts the response off Positive feedback: the response reinforces the stimulus Notch Ac,va,on Myt1 Ngn3 Endocrine differen,a,on Muta,ons • Some muta,ons influence produc,on of a protein (stop a protein from being made at all or cause it to be made all the ,me) • Other muta,ons influence when a protein is ac,ve versus off or whether the protein func,ons to perform its task properly 3 Strike Rule Mutations happen all the time but normally cell detects mutation and repairs it. If it can’t repair there are pathways that tell the cell to commit suicide Most mutations occur in genes that regulate the following pathways: cell division programmed cell death DNA repair Oncogenes • Proto‐oncogene: normal, good gene • Oncogene: mutated gene leading to unregulated cell growth (Usually acquired muta,ons by chromosome rearrangement, gene duplica,on, muta,on) • i.e. Chronic Myeloid leukemia (CML) is a rearrangement that forms BCR‐ABL gene • (Tyrosine Kinase)…treat with ima,nib/ dasa,nib Tumor Suppressors • Genes that normally slow down cell division, DNA repair mistakes and tell cells when to undergo programmed cell death • Inac,va,on of these genes results in unregulated growth and cancer • i.e. p53 (found in %50 of human cancer, 70% colon cancers, 30‐50% breast cancer, 50% lung cancers), BRCA1, BRCA2 P53 is part of apopto,c pathway Inactivates p53 Drug interac,ons Molecules that bind to a receptor but do not produce an effect are called antagonists, whereas those that bind to a receptor and induce a response are termed agonists. The ligand is frequently referred to as a hormone or drug. Blood glucose Eat a meal Stretch receptors *Pax4 expression converts Alpha cells to insulin producing Beta cells CNS Pancreas Insulin Type 2 diabetes a resistance to the ac,on of insulin in target cells ‐ especially in muscle, ‐ fat and liver cells. Target tissues Glucose uptake Blood Glucose Type 1 diabetes is caused by a lack of insulin output * Tyrosine kinase inhibitors (TKIs) Therapeu,c strategies include: blocking kinase‐substrate interac,on inhibi,ng the enzyme's ATP binding site blocking extracellular receptors on tumour cells. Breast cancer is the second leading cause of cancer deaths in women in the US Approximately 15‐30% of breast cancers are HER2‐posi,ve In 25‐30% of pa,ents with metasta,c breast cancer, HER2 is overexpressed due to amplifica,on of the HER2 gene *American Cancer Society. Cancer Facts and Figures 2009. hlp://www.cancer.org. Accessed May 5, 2009. cetuximab targets ERBB1 for treatment of colorectal cancer. Y kinase inhibitor used for small lung cancer treatment Compe,,ve inhibitors prevent ligand binding by blocking site